Service Detail
NaProTECHNOLOGY (Natural Procreative Technology) is a science-based approach to monitoring and maintaining reproductive health that works cooperatively with a woman's natural cycle to identify and treat underlying causes of infertility, recurrent miscarriage, and gynecological conditions.
Initial Assessment & Education (Weeks 1-4)
Complete medical history and physical examination, introduction to fertility charting methodology, first cycle observation and baseline charting, initial hormone testing at specific cycle points
Diagnostic Phase (Cycles 1-3)
Detailed cycle charting and analysis, comprehensive hormone profiling across the cycle, ultrasound monitoring of follicle development, identification of ovulatory dysfunction or luteal phase defects, additional testing for underlying conditions
Treatment Phase (Cycles 4-12)
Targeted hormone therapy based on cycle analysis, surgical intervention if anatomical issues identified, medication adjustments based on cycle response, optimized timing for natural conception, continuous monitoring and chart review
Ongoing Support & Follow-up
Regular practitioner reviews of fertility charts, medication adjustments as needed, pre-conception and early pregnancy support, post-conception monitoring and progesterone support
NaProTECHNOLOGY focuses on identifying and treating the underlying causes of infertility rather than bypassing them. It works cooperatively with your natural cycle through detailed charting and targeted interventions, allowing for natural conception while addressing root hormonal or anatomical issues.
Most couples need 6-12 months of charting and treatment. However, some see results within 3-6 cycles, while complex cases may take longer. The comprehensive diagnostic phase alone takes 2-3 cycles to identify all underlying issues accurately.
Yes, NaProTECHNOLOGY can complement other approaches. The detailed cycle knowledge gained through charting can improve the timing and effectiveness of procedures like IUI. Some couples use NaPro principles alongside or before considering IVF.
Success rates vary based on underlying diagnosis but range from 25-60% for achieving pregnancy within the first year of treatment, with higher rates for specific conditions like luteal phase deficiency or cervical mucus abnormalities.
NaProTECHNOLOGY is most effective for couples with ovulatory dysfunction, hormonal imbalances, recurrent miscarriage, or unexplained infertility. It may not be the first choice for severe male factor infertility, bilateral tubal blockage, or advanced maternal age.
